A review of delusions of parasitosis, part 1: Presentation and diagnosis

Cutis

Volumn 82, Issue 2, 2008, Pages 123-130

  Bak, Rachel ^a,f   Tumu, Phani ^b   Hui, Christina ^c   Kay, David ^d   Burnett, Julie ^e   Peng, David ^e  

^a Northridge Hospital Medical Center   (United States)

^b LAC USC MEDICAL CENTER   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d CITY UNIVERSITY OF NEW YORK   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CLASSIFICATION; DELUSION; DIFFERENTIAL DIAGNOSIS; HUMAN; PARASITOSIS; PSYCHOLOGICAL ASPECT; REVIEW;

ANTIPSYCHOTIC AGENTS; DELUSIONS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PARASITIC DISEASES;

EID: 51049100205     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Thiebierge G. Les acarophobes. Rev Gen Clin Ther. 1894;32:373.
2. McFarland AR. Mechanical trauma. AMA Arch Derm Syphilol. 1953;67:278-283.
3. Wilson JW, Miller HE. Delusions of parasitosis. Arch Dermatol Syph. 1946;54:39-56.
4. Koblenzer CS. Psychocutaneous disease. Orlando, FL: Gruna & Stratton; 1987.
5. Saverly VR, Leitao MM, Stricker RB. The mystery of Morgellons disease: infection or delusion? Am J Clin Dermatol. 2006;7:1-5.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
7. Bishop ER. Monosymptomatic hypochondriacal syndromes in dermatology. J Am Acad Dermatol. 1983;9:152-158.
8. Koo J, Gambla C. Delusions of parasitosis and other forms of monosymptomatic hypochondriacal psychosis. Dermatol Clin. 1996;14:429-438.
9. Koo J, Pham CT. Psychodermatology. practical guidelines on pharmacotherapy. Arch Dermatol, 1992;128:381-388.
10. Lyell A. The Michelson Lecture, delusions of parasitosis. Br J Dermatol. 1983;108:485-499.
11. Munro A, Chmara J. Monosymptomatic hypochondriacal psychosis: a diagnostic checklist based on 50 cases of the disorder. Can J Psychiatry, 1982;27:374-376.
12. Driscoll MS, Rothe MJ, Grant-Kels JM, et al. Delusional parasitosis: a dermatologic, psychiatric, and pharmacologic approach. J Am Acad Dermatol. 1993;29:1023-1033.
13. Wilson JW. Delusion of parasitosis (acarophobia). AMA Arch Derm Syphilol. 1952;66:577-585.
14. Marneros A, Deister A, Rohde A. Delusional parasitosis: a comparative study to late-onset schizophrenia and organic mental disorders due to cerebral arteriosclerosis. Psychopathobgy. 1988;21:267-274.
15. Schrut AH, Waldron WG. Psychiatric and entomological aspects of delusory parasitosis. entomophobia, acarophobia, dermatophobia. JAMA. 1963;186:429-430.
16. Ungvari G, Vladar K. Pimozide treatment for delusion of infestation. Act Nerv Super (Praha). 1986;28:103-107.
17. Bhatia MS, Jagawat T, Choudhary S. Delusional parasitosis: a clinical profile. Int J Psychiatry Med. 2000;30:83-91.
18. Tandon AK. A psychosocial study of delusional parasitosis, Indian J Psychiatr. 1990;32:252-255.
19. Srinivasan TN, Suresh TR, Jayaram V, et al. Nature and treatment of delusional parasitosis: a different experience in India. Int J Dermatol. 1994;33:851-855.
20. Sheppard NP, O'Loughlin S, Malone JP. Psychogenic skin disease: a review of 35 cases. Br J Psychiatry. 1986;149; 636-643.
21. Aw DC, Thong JY, Chan HL. Delusional parasitosis: case series of 8 patients and review of the literature. Ann Acad Med Singapore. 2004;33:89-94.
22. Reilly TM, Batchelor DH. The presentation and treatment of delusional parasitosis: a dermatological perspective. Int Clin Psychopharmocol. 1986;1:340-353.
23. Skott A. Delusions of infestation. In: Report From the Psychiatric Research Centre, No. 13. Goteborg, Sweden: St Jorgen's Hospital, University of Goteborg; 1978.
24. Musalek M, Kutzer E. The frequency of shared delusions in delusions of infestation. Eur Arch Psychiatry Neurol Sci. 1990;239:263-266.
25. Bourgeois ML, Duhamel P, Verdoux H. Delusional parasitosis: folie a deux and attempted murder of a family doctor. Br J Psychiatry. 1992;161:709-711.
26. Ford EB, Calfee DP, Pearson RD. Delusions of intestinal parasitosis. South Med J. 2001;94:545-547.
27. Freyne A, Wrigley M. Delusion infestation in an elderly population. Ir Med J. 1994;87:86-88.
28. Gould WM, Gragg TM. Delusions of parasitosis. an approach to the problem. Arch Dermatol. 1976;112:1745-1748.
29. Hamann K, Avnstorp C. Delusions of infestation treated by pimozide: a double-blind crossover clinical study. Acta Derm Venereol. 1982;62:55-58.
30. Harper R, Moss G. Delusional infestation associated with post-herpetic neuralgia and EEG abnormalities. Br J Psychiatry. 1992;161:411-412.
31. Hunt NJ, Blacker VR. Delusional parasitosis. Br J Psychiatry, 1987;150:713-714.
32. Kalivas J, Kalivas L. Setraline: lack of therapeutic efficacy in patients with delusions of parasitosis and dermatitis artefacta. Int J Dermatol. 1997;36:477.
33. Kim C, Kim J, Lee M, et al. Delusional parasitosis as "folie a deux." J Korean Med Sci. 2003;18:462-465.
34. Le L, Gonski PN. Delusional parasitosis mimicking cutaneous infestation in elderly patients. Med J Aust. 2003;179:209-210.
35. Lindskov R, Baadsgaard O. Delusions of infestation treated with pimozide, a follow-up study. Acta Derm Venereol. 1985;65:267-270.
36. Meehan WJ, Badreshia S, Mackley CL. Successful treatment of delusions of parasitosis with olanzapine. Arch Dermatol. 2006;142:352-355.
37. Mick RL, Rosen DH, Smith RC. Delusions of parasitosis: healing impact of the physician-patient relationship. Psychosomatics. 1987;28:596-598.
38. Makhija M, Bhalerao S. Reconsidering pimozide for new-onset delusions of parasitosis. Can J Psychiatry. 2004;49:643-644.
39. Mitchell C. Successful treatment of chronic delusional parasitosis. Br J Psychiatry. 1989;155:556-557.
40. Munro A. Monosymptomatic hypochondriacal psychosis manifesting as delusions of parasitosis: a description of four cases successfully treated with pimozide. Arch Dermatol. 1978;114:940-943.
41. Räsänen P, Kari Erkonen K, Isaksson U, et al. Delusional parasitosis in the elderly: a review and report of six cases from northern Finland. Int Psychogeriatr. 1997;9: 459-464.
42. Reilly TM, Jopling WH, Beard AW. Successful treatment with pimozide of delusional parasitosis. Br J Dermatol. 1978;98:457-459.
43. Renvoize EB, Kent J, Klar HM. Delusional infestation and dementia: a case report. Br J Psychiatry. 1987;150: 403-405.
44. Roberts J, Roberts R. Delusions of parasitosis. Br Med J. 1977;1:1219.
45. Shah PA. Delusions of parasitosis. South Med J. 1988;81:939-940.
46. Torch EM, Bishop ER Jr. Delusions and parasitosis: psychotherapeutic engagement. Am J Psychother. 1981;35: 101-106.
47. Tullett GL. Delusions of parasitosis. Br J Dermatol. 1965;77:448-455.
48. Wenning MT, Davy LE, Catalano G, et al. Atypical anti-psychotics in the treatment of delusional parasitosis. Ann Clin Psychiatry. 2003;15:233-239.
49. Wessely S. Delusional parasitosis. Br J Psychiatry. 1987;151:560-561.
50. Zomer SF, De Wit RF, Van Bronswijk JE, et al. Delusions of parasitosis. a psychiatric disorder to be treated by dermatologists? an analysis of 33 patients. Br J Dermatol. 1998;138:1030-1032.
51. Amancio EJ, Peluso CM, Santos AC. Ekbom's syndrome and spasmodic torticollis: case report. Arq Neuropsiquiatr. 2002;60:155-158.
52. Bhatia MS, Gautam RK, Shome S, et al. Delusional parasitosis with trichotillomania. J Indian Medl Assoc. 1994;92:389.
53. Bond WS. Delusions of parasitosis: a case report and management guidelines. DICP. 1989;23:304-306.
54. Damiani JT, Flowers FP, Pierce DK. Pimozide in delusions of parasitosis. J Am Acad Dermatol. 1990;22(2, pt 1): 312-313.
55. Duke EE. Clinical experience with pimozide: emphasis on its use in postherpetic neuralgia. J Am Acad Dermatol. 1983;8:845-850.
56. Gieler U, Knoll M. Delusional parasitosis as 'folie a trois'. Dermatologica. 1990;181:122-125.
57. Goddard J. Analysis of 11 cases of delusions of parasitosis reported to the Mississippi Department of Health. South Med J. 1995;88:837-839.
58. Quirino CJ, Carlos EPC. Delusional parasitic and folie à deux: case report. Arq Neuro-Psiquiatr. 2003;61(3B):872-875.
59. Shelley WB, Shelley ED. Delusions of parasitosis associated with coronary bypass surgery. Br J Dermatol. 1988;118:309-310.
60. Hanumantha K, Pradhan PV, Suvarna B. Delusional parasitosis-study of 3 cases. J Postgrad Med. 1994;40: 222-224.
61. Sherman MD, Holland GN, Holsclaw DS, et al. Delusions of ocular parasitosis. Am J Ophthalmol. 1998;125:852-856.
62. Hopkinson G. Delusions of infestation. Acta Psychiatr Scand. 1970;46:111-119.
63. Sugahara H, Otani Y, Sakamoto M. Delusional parasitosis accompanied by word deafness due to cerebral infarction: folie a deux. Psychosomatics. 2000;41:447-448.
64. Holmes VF. Treatment of monosymptomatic hypochondriacal psychosis with pimozide in an AIDS patient. Am J Psychiatry. 1989;146:554-555.
65. Paulson MJ, Petrus EP. Delusions of parasitosis: a psychological study. Psychosomatics. 1969;10:111-120.
66. Oruc L, Bell P. Multiple rape trauma followed by delusional parasitosis: a case report from the Bosnian war. Schizophr Res. 1995;16:173-174.
67. Kuruppuarachchi KA, Williams SS. Delusional parasitosis. Ceylon Med J. 2003;48:96-97.
68. Andrews E, Bellard J, Walter-Ryan WG. Monosymptomatic hypochondriacal psychosis manifesting as delusions of infestation: case studies of treatment with haloperidol. J Clin Psychiatry. 1986;47:188-190.
69. Riding J, Munro A. Pimozide in the treatment of mono-symptomatic hypochondriacal psychosis. Acta Psychiatr Scand. 1975;52:23-30.
70. Safer DL, Wenegrat B, Roth WT. Risperidone in the treatment of delusional parasitosis: a case report. J Clin Psychopharmacol, 1997;17:131-132.
71. Nicolato R, Correa H, Romano-Silva MA, et al. Delusional parasitosis or Ekbom syndrome: a case series. Gen Hosp Psych. 2006;28:85-87.
72. May WW, Terpenning MS. Delusional parasitosis in geriatric patients. Psychosomatics. 1991;32:88-94.
73. Bhatia MS, Chandra R, Kamra A. Delusional parasitosis in leprosy. Indian J Lepr. 2002;74:159-160.
74. Stephens MB. Delusions of parasitosis. Am Fam Physician. 1999;60:2507-2508.
75. Slaughter JR, Zanol K, Rezvani H, et al. Psychogenic parasitosis, a case series and literature review. Psychosomatics. 1998;39:491-500.
76. Nagaratnam N, O'Neile L. Delusional parasitosis following occipito-temporal cerebral infarction. Gen Hosp Psychiatry. 2000;22:129-132.
77. Zanol K, Slaughter J, Hall R. An approach to the treatment of psychogenic parasitosis. Int J Dermatol. 1998;37:56-63.
78. Johnson OC, Anton RF. Delusions of parasitosis: differential diagnosis and treatment. South Med J. 1985;78: 914-918.
79. De Leon J, Antelo RE, Simpson G. Delusion of parasitosis or chronic tactile hallucinosis: hypothesis about their brain physiopathology. Compr Psychiatry. 1992;33:25-33.
80. Lyell A. Delusions of parasitosis. J Am Acad Dermatol. 1983;8:895-897.
81. Johnson GC, Anton RF. Pimozide in delusions of parasitosis [letter]. J Clin Psychiatry. 1983;44:233.
82. Botschev C, Muller N. Opiate receptor antagonists for delusions of parasitosis. Biol Psychiatry. 1991;30:530-531.
83. Munro A. Monosymptomatic hypochondriacal psychosis. Br J Hosp Med. 1980;24:34, 36-38.
84. Ellison GD, Eison MS. Continuous amphetamine intoxication: an animal model of the acute psychotic episode. Psychol Med. 1983;13:751-761.
85. Liebaldt G, Klages W. Morphological findings in an "isolated chronic tactile dermatozoan hallucinosis" [in German]. Nervenarzt. 1961;32:157-171.
86. King BH. Hypothesis: involvement of the serotonergic system in the clinical expression of monosymptomatic hypochondriasis. Pharmacopsychiatry. 1990;23:85-89.
87. Lee WR. The matchbox sign [editorial]. Lancet. 1983;2(8344):261.
88. Musalek M, Bach M, Passweg V, et al. The position of delusional parasitosis in psychiatric nosology and classification. Psyche-pathology. 1990;23:115-124.
89. Morris M, Jolley DJ. Delusional infestation in late life [letter]. Br] Psychiatry. 1987;151:272.
90. Baker PB, Cook BL, Winokur G. Delusional infestation. the interface of delusions and hallucinations. Psychiatr Clin North Am. 1995;18:345-361.
91. Brady KT, Lydiard RB, Malcolm R, et al. Cocaine-induced psychosis. J Clin Psychiatry. 1991;52:509-512.
92. Siegel RK. Cocaine hallucinations. Am J Psychiatry. 1978;135:309-314.
93. Elpern DJ. Cocaine abuse and delusions of parasitosis. Cutis. 1988;42:273-274.
94. Marschall MA, Dolezal RF, Cohen M, et al. Chronic wounds and delusions of parasitosis in the drug abuser. Plast Reconstr Surg. 1991;88:328-330.
95. Spensley J, Rockwell DA. Psychosis during methylphenidate abuse. N Engl J Med. 1972;286: 880-881.
96. Gross-Tsur V, Joseph A, Shalev RS. Hallucinations during methylphenidate therapy. Neurology. 2004;63:753-754.
97. Young JG. Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action. J Dev Behav Pediatr. 1981;2:35-38.
98. Catalano MC, Glass JM, Catalano G, et al. Gamma butyrolactone (GBL) withdrawal syndromes. Psychosomatics. 2001;42:83-88.
99. Aizenberg D, Schwartz B, Zemishlany Z. Delusional parasitosis associated with phenelzine. Br J Psychiatry. 1991;159:716-717.
100. Liebowitz MR, Nuetzel EJ, Bowzer AE, et al. Phenelzine and delusions of parasitosis: a case report. Am J Psychiatry. 1978;135:1565-1566.
101. Krauseneck T, Soyka M. Delusional parasitosis associated with pemoline. Psychopathology. 2005;38:103-104.
102. Swick BL, Walling HW. Drug-induced delusions of parasitosis during treatment of Parkinson's disease. J Am Acad Dermatol. 2005;53:1086-1087.
103. 12 deficiency. Practitioner. 1970;204:421-422.
104. Aleshire I. Delusion of parasitosis: report of successful care with antipellagrous treatment. JAMA. 1954;155:15-17.
105. Berrios GE. Delusional parasitosis and physical disease. Comp Psychiatry. 1985;2:395-403.
106. Blasco-Fontecilla H, Bragado Jiménez MD, Garcia Santos LM, et al. Delusional disorder with delusions of parasitosis and jealousy after stroke: treatment with quetiapine and sertraline. J Clin Psychopharmacol. 2005;25:615-617.
107. Wykoff RE. Delusions of parasitosis: a review. Rev Infect Dis. 1987;9:433-437.
108. Verdoux H, Maurice-Tison S, Gay B, et al. A survey of delusional ideation in primary-care patients. Psychol Med. 1998;28:127-134.